Skip to main content
Industry News
MACPAC wants states to have more time to make drug coverage decisions

The Medicaid and CHIP Payment and Access Commission agreed to recommend that Congress give states a 180-day grace period to evaluate a new drug's effectiveness before deciding whether to cover that drug. The commission's members also want lawmakers to eliminate a cap on Medicaid drug rebates.

Full Story: